Incidence, Severity and Impact of Influenza: a joint meeting organised by the ISIRV Epidemiology Group and ECDC, Stockholm, 2019

References

1. Kumar D, Ferreira VH, Blumberg E, Silveira F, Cordero E, Perez-Romero P, et al. A 5-Year Prospective Multicenter Evaluation of Influenza Infection in Transplant Recipients. Clin Infect Dis. 2018;67(9):1322-9.  https://doi.org/10.1093/cid/ciy294  PMID: 29635437 
2. Uyeki TM, Bernstein HH, Bradley JS, Englund JA, File TM, Fry AM, et al. Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenzaa. Clin Infect Dis. 2019;68(6):895-902.  https://doi.org/10.1093/cid/ciy874  PMID: 30834445 
3. Fragaszy EB, Warren-Gash C, Wang L, Copas A, Dukes O, Edmunds WJ, et al. , Flu Watch Group. Cohort Profile: The Flu Watch Study. Int J Epidemiol. 2017;46(2):e18. PMID: 26940466 
4. Rath B, Maltezou HC, Papaevangelou V, Papagrigoriou-Theorodridou MA, Alchikh M, Myles P, et al. Partnering for Enhanced Digital Surveillance of Influenza-like Disease and the Effect of Antivirals and Vaccines (PEDSIDEA). Influenza Other Respir Viruses. 2019;00:1-10 https://doi.org/10.1111/irv.12645 
5. Milne GJ, Halder N, Kelso JK, Barr IG, Moyes J, Kahn K, et al. Trivalent and quadrivalent influenza vaccination effectiveness in Australia and South Africa: results from a modelling study. Influenza Other Respir Viruses. 2016;10(4):324-32.  https://doi.org/10.1111/irv.12367  PMID: 26663701 
6. Xu L, Bao L, Zhou J, Wang D, Deng W, Lv Q, et al. Genomic polymorphism of the pandemic A (H1N1) influenza viruses correlates with viral replication, virulence, and pathogenicity in vitro and in vivo. PLoS One. 2011;6(6):e20698.  https://doi.org/10.1371/journal.pone.0020698  PMID: 21698272 
7. Reich NG, Brooks LC, Fox SJ, Kandula S, McGowan CJ, Moore E, et al. A collaborative multiyear, multimodel assessment of seasonal influenza forecasting in the United States. Proc Natl Acad Sci USA. 2019;116(8):3146-54.  https://doi.org/10.1073/pnas.1812594116  PMID: 30647115 
8. Britton PN, Dale RC, Blyth CC, Macartney K, Crawford NW, Marshall H, et al. , ACE study investigators and PAEDS network. Influenza-associated Encephalitis/Encephalopathy Identified by the Australian Childhood Encephalitis Study 2013-2015. Pediatr Infect Dis J. 2017;36(11):1021-6.  https://doi.org/10.1097/INF.0000000000001650  PMID: 28654561 
9. Rabarison JH, Tempia S, Harimanana A, Guillebaud J, Razanajatovo NH, Ratsitorahina M, et al. Burden and epidemiology of influenza- and respiratory syncytial virus-associated severe acute respiratory illness hospitalization in Madagascar, 2011-2016. Influenza Other Respir Viruses. 2019;13(2):138-47.  https://doi.org/10.1111/irv.12557  PMID: 30596225 
10. World Health Organization (WHO). Global influenza strategy 2019–2030. Geneva: WHO; 2019. Available from: https://www.who.int/influenza/global_influenza_strategy_2019_2030/en/